Date Filed | Type | Description |
08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/08/2023 |
4
| Wirick Angela L (CFO) has filed a Form 4 on AtriCure, Inc.
Txns:
| Paid exercise price by delivering 5,191 shares
@ $57.23, valued at
$297.1k
|
|
08/08/2023 |
4
| CARREL MICHAEL H (President, CEO, & Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 1,250 shares
@ $0 |
|
07/28/2023 |
4
| Dahlquist Karl S. (Chief Legal Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 3,417 shares
@ $57.09, valued at
$195.1k
|
|
07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/26/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
07/26/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
07/26/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/25/2023 |
8-K
| Quarterly results |
07/03/2023 |
4
| Yount Deborah Lee (Chief Human Resources Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 450 shares
@ $38.11, valued at
$17.1k
|
|
07/03/2023 |
4
| Seith Douglas J (COO) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 557 shares
@ $38.11, valued at
$21.2k
|
|
07/03/2023 |
4
| Privitera Salvatore (Chief Technical Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 557 shares
@ $38.11, valued at
$21.2k
|
|
07/03/2023 |
4
| Noznesky Justin J (Chief Mktg & Strategy Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 547 shares
@ $38.11, valued at
$20.8k
|
|
07/03/2023 |
4
| Doraiswamy Vinayak (Chief Scientific Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 557 shares
@ $38.11, valued at
$21.2k
|
|
07/03/2023 |
4
| Dahlquist Karl S. (Chief Legal Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 557 shares
@ $38.11, valued at
$21.2k
|
|
07/03/2023 |
4
| CARREL MICHAEL H (President, CEO, & Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 557 shares
@ $38.11, valued at
$21.2k
|
|
06/12/2023 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 713 shares
@ $47.89, valued at
$34.1k
|
|
06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/07/2023 |
4
| Dahlquist Karl S. (Chief Legal Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 1,422 shares
@ $47.03, valued at
$66.9k
|
|
06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/01/2023 |
4
| CARREL MICHAEL H (President, CEO, & Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 1,000 shares
@ $0 |
|
05/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/26/2023 |
4
| WHITE ROBERT S. (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| WEHRWEIN SVEN (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| Telman Deborah H (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| JOHNSON B KRISTINE (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| GROVES REGINA E (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
4
| Yuen Maggie (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 3,186 shares
@ $0 |
|
05/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/24/2023 |
SD
| Form SD - Specialized disclosure report: |
05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/15/2023 |
4
| Collar Mark A (Director) has filed a Form 4 on AtriCure, Inc.
Txns:
| Exercised 10,000 options to buy
@ $9.3, valued at
$93k
|
|
|